Metopimazine

美托哌丙嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMetopimazine
Drug Alias Name甲磺哌丙嗪metopimazinummetopimazinaVogalibVogaline +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsVomitingNausea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsVomitingNausea
Inactive IndicationsN/A

Other Information

ATC CodeA04AD05
Related LinksWikipediaKEGG